CD127 (the IL7-receptor) also commonly marks TCM, but exhibited a different pattern than CCR7, as it trended to higher levels (amongst CD8+ T-cells) or is significantly elevated (amongst CD4+ T-cells) in PDA and CCA compared to HCC. Here, CD8A is linked to Patent ductus arteriosus.